NewGenIvf Group (NIVF) Competitors $0.33 -0.01 (-2.46%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends NIVF vs. MGRX, VSEE, ATPC, BGLC, ATIP, ACON, CMAX, BACK, GBNHF, and UPHLShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Mangoceuticals (MGRX), Vsee Health (VSEE), Agape ATP (ATPC), BioNexus Gene Lab (BGLC), ATI Physical Therapy (ATIP), Aclarion (ACON), CareMax (CMAX), IMAC (BACK), Greenbrook TMS (GBNHF), and UpHealth (UPHL). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Mangoceuticals Vsee Health Agape ATP BioNexus Gene Lab ATI Physical Therapy Aclarion CareMax IMAC Greenbrook TMS UpHealth NewGenIvf Group (NASDAQ:NIVF) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation. Does the media favor NIVF or MGRX? In the previous week, Mangoceuticals had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 2 mentions for Mangoceuticals and 1 mentions for NewGenIvf Group. Mangoceuticals' average media sentiment score of 0.74 beat NewGenIvf Group's score of 0.17 indicating that Mangoceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NewGenIvf Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mangoceuticals 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer NIVF or MGRX? NewGenIvf Group and Mangoceuticals both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformNewGenIvf GroupN/AN/AMangoceuticalsN/AN/A Is NIVF or MGRX more profitable? NewGenIvf Group has a net margin of 0.00% compared to Mangoceuticals' net margin of -1,237.00%. NewGenIvf Group's return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets NewGenIvf GroupN/A N/A N/A Mangoceuticals -1,237.00%-138.00%-118.88% Do institutionals & insiders hold more shares of NIVF or MGRX? 66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by company insiders. Comparatively, 39.3% of Mangoceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has stronger earnings and valuation, NIVF or MGRX? NewGenIvf Group has higher revenue and earnings than Mangoceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNewGenIvf Group$5.14M0.66$130KN/AN/AMangoceuticals$755K8.17-$9.21M-$5.79-0.43 Which has more risk & volatility, NIVF or MGRX? NewGenIvf Group has a beta of -0.12, meaning that its share price is 112% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500. SummaryNewGenIvf Group beats Mangoceuticals on 6 of the 11 factors compared between the two stocks. Ad Brownstone ResearchMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.47M$1.91B$5.14B$9.08BDividend YieldN/A7.04%5.09%4.23%P/E RatioN/A15.5790.0517.18Price / Sales0.663.171,117.14116.99Price / Cash9.619.7743.0437.86Price / Book3.033.044.784.78Net Income$130,000.00$69.56M$120.31M$225.60M7 Day Performance4.98%-1.73%-1.92%-1.23%1 Month Performance-38.68%-2.76%11.51%3.36%1 Year PerformanceN/A-25.02%30.61%16.60% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf Group0.4995 of 5 stars$0.33-2.5%N/AN/A$3.47M$5.14M0.00N/AGap DownMGRXMangoceuticals1.1789 of 5 stars$2.51-1.2%N/A-96.2%$6.25M$730,000.000.003News CoveragePositive NewsGap DownVSEEVsee HealthN/A$1.68+5.0%N/AN/A$6.05MN/A0.00N/ANews CoverageATPCAgape ATPN/A$1.45-2.4%N/A-88.5%$5.79M$1.43M0.0040Positive NewsGap DownBGLCBioNexus Gene LabN/A$0.30+3.1%N/A-61.5%$5.39M$9.26M0.0030Positive NewsGap UpATIPATI Physical Therapy0.0621 of 5 stars$0.75+74.4%N/A-61.4%$3.31M$699.02M0.005,600Gap UpHigh Trading VolumeACONAclarion1.8597 of 5 stars$0.17+1.3%$1.30+682.7%-97.8%$1.73M$80,000.000.007Gap DownCMAXCareMax0.866 of 5 stars$0.42-26.2%N/A-96.8%$1.61M$751.10M0.001,450Gap DownBACKIMACN/A$1.18+6.3%N/A-19.3%$1.36M$16.19M0.00180Earnings ReportNews CoverageGBNHFGreenbrook TMSN/A$0.02+36.4%N/AN/A$612,000.00$73.79M0.00430Gap DownUPHLUpHealthN/A$0.00+33.3%N/A-99.8%$8,000.00$130M0.001,750Gap Down Related Companies and Tools Related Companies Mangoceuticals Alternatives Vsee Health Alternatives Agape ATP Alternatives BioNexus Gene Lab Alternatives ATI Physical Therapy Alternatives Aclarion Alternatives CareMax Alternatives IMAC Alternatives Greenbrook TMS Alternatives UpHealth Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NIVF) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.